BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19527106)

  • 1. Reovirus-based therapy for cancer.
    Kelly K; Nawrocki S; Mita A; Coffey M; Giles FJ; Mita M
    Expert Opin Biol Ther; 2009 Jul; 9(7):817-30. PubMed ID: 19527106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reovirus: Rationale and clinical trial update.
    Lal R; Harris D; Postel-Vinay S; de Bono J
    Curr Opin Mol Ther; 2009 Oct; 11(5):532-9. PubMed ID: 19806501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic viral therapy using reovirus.
    Thirukkumaran C; Morris DG
    Methods Mol Biol; 2009; 542():607-34. PubMed ID: 19565924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug evaluation: Reolysin--wild-type reovirus as a cancer therapeutic.
    Stoeckel J; Hay JG
    Curr Opin Mol Ther; 2006 Jun; 8(3):249-60. PubMed ID: 16774045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reovirus - possible therapy of cancer.
    Figova K; Hrabeta J; Eckschlager T
    Neoplasma; 2006; 53(6):457-62. PubMed ID: 17167712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of immunohistochemistry to determine oncolytic reovirus distribution and replication in-human tumors.
    Kapadia R; Coffey MC
    Methods; 2010 Dec; 52(4):301-6. PubMed ID: 20801221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reovirus: viral therapy for cancer 'as nature intended'.
    Comins C; Heinemann L; Harrington K; Melcher A; De Bono J; Pandha H
    Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):548-54. PubMed ID: 18583112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of oncolytic reovirus against human breast cancer cells.
    Hata Y; Etoh T; Inomata M; Shiraishi N; Nishizono A; Kitano S
    Oncol Rep; 2008 Jun; 19(6):1395-8. PubMed ID: 18497942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts.
    Hingorani P; Zhang W; Lin J; Liu L; Guha C; Kolb EA
    Cancer; 2011 Apr; 117(8):1764-74. PubMed ID: 21472724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reovirus and tumor oncolysis.
    Kim M; Chung YH; Johnston RN
    J Microbiol; 2007 Jun; 45(3):187-92. PubMed ID: 17618222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in oncolytic viral therapy.
    Woo Y; Adusumilli PS; Fong Y
    Curr Opin Investig Drugs; 2006 Jun; 7(6):549-59. PubMed ID: 16784026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer.
    Vidal L; Pandha HS; Yap TA; White CL; Twigger K; Vile RG; Melcher A; Coffey M; Harrington KJ; DeBono JS
    Clin Cancer Res; 2008 Nov; 14(21):7127-37. PubMed ID: 18981012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic Viral Therapy Using Reovirus.
    Thirukkumaran C; Morris DG
    Methods Mol Biol; 2015; 1317():187-223. PubMed ID: 26072409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reovirus therapy in cancer: has the orphan virus found a home?
    Yap TA; Brunetto A; Pandha H; Harrington K; Debono JS
    Expert Opin Investig Drugs; 2008 Dec; 17(12):1925-35. PubMed ID: 19012507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring host factors that impact reovirus replication, dissemination, and reovirus-induced cell death in cancer versus normal cells in culture.
    Shmulevitz M; Lee PW
    Methods Mol Biol; 2012; 797():163-76. PubMed ID: 21948476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Not all viruses are bad guys: the case for reovirus in cancer therapy.
    Norman KL; Lee PW
    Drug Discov Today; 2005 Jun; 10(12):847-55. PubMed ID: 15970267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors.
    Roulstone V; Khan K; Pandha HS; Rudman S; Coffey M; Gill GM; Melcher AA; Vile R; Harrington KJ; de Bono J; Spicer J
    Clin Cancer Res; 2015 Mar; 21(6):1305-12. PubMed ID: 25424857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic reovirus therapy of metastatic cancer in immune-competent mice.
    Hirasawa K; Nishikawa SG; Norman KL; Coffey MC; Thompson BG; Yoon CS; Waisman DM; Lee PW
    Cancer Res; 2003 Jan; 63(2):348-53. PubMed ID: 12543787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy.
    Twigger K; Vidal L; White CL; De Bono JS; Bhide S; Coffey M; Thompson B; Vile RG; Heinemann L; Pandha HS; Errington F; Melcher AA; Harrington KJ
    Clin Cancer Res; 2008 Feb; 14(3):912-23. PubMed ID: 18245555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.